The rational design of new peptide-based drugs requires compounds with improved stability towards proteolytic cleavage on physiological systems, and a lessening of the peptide's intrinsic flexibility in order to obtain the effective conformation required for receptor binding. These requirements have been achieved by insertion of rigid non-peptide moieties into the appropriate site of the peptide backbone. This is a common approach to restrict the conformational degrees of freedom or stabilization of secondary structures that favors the binding to receptors. 1 In this context, many structurally rigid amino acids have been designed. Among them, heteroaromatic amino acids have recently attracted much attention, 2 and have been assembled into peptidomimetics for the purpose of drug discovery. 3 As part of our continuing interest in the synthesis and biological applications of chiral furan amino acids, 4 we present the synthesis of constrained analogues of D-and Lserine (1 and ent-1, Scheme 1) as novel scaffolds for the synthesis of non-proteinogenic peptides. Given that complex biochemical processes involve molecular recognition based not only on polar but also on hydrophobic interactions, the structure of our targets is of interest because they contain an alkyl furan moiety which increases the rigidity and hydrophobicity. 5 In addition, constrained serine analogues incorporated into peptides have been reported to clarify the conformational role of the hydroxymethyl group 6 and several serine analogues have been reported with this goal.
7
The stereoselective introduction of an amino function into the a-position of a furan moiety has been widely studied 8 due to their interest as building blocks for the synthesis of azasugar derivatives 9 such as piperidine alkaloids, indolizidines and quinolizidines through the aza-Achmatowicz rearrangement.
10
Here we report a novel stereoselective route for the synthesis of a-furfuryl amines and their transformation into D-and L-serine analogues. This methodology implies a nucleophilic displacement by azido anions on the intermediate sulfites that were obtained starting from D-xylose and D-arabinose, respectively (Scheme 1). Additionally, our target compounds are analogues of b-hydroxy-a-amino acids, which are constituents of many biologically active natural products and medicinally important compounds.
11

Scheme 1
Thus, the reaction of D-xylose and D-arabinose with benzyl acetoacetate in the presence of ZnCl 2 as catalyst 12 afforded trihydroxypropyl furans 2 and 3, respectively, in moderate to good yield (Scheme 2). The trihydroxypropyl derivatives were obtained with good stereoselectivities which implies almost no epimerization at C-1¢ of the polyolic chain (S/R = 36 for 2 and R/S = 19 for 3). Recently, it has been reported that the reaction of aldopentoses and other sugars including disaccharides with b-dicarbonyl compounds can be performed using CeCl 3 as catalyst. 13 In our hands, the condensation of D-xylose and D-arabinose with benzyl acetoacetate and CeCl 3 (25%), provoked the total epimerization at C-1¢ after six hours of reaction, which is in contradiction with the results reported in the literature. chain of a tetrahydroxybutylfuran derivative, we have recently reported 14 on the regioselective chlorination at C-1¢ followed by nucleophilic displacement with an azido anion. However, this procedure is poorly stereoselective giving a mixture of epimers at C-1¢ in a 2:1 ratio.
We present in this letter a methodology that improves this functionalization in order to obtain a-furfuryl amino derivatives with high stereoselectivity and good yield. Reaction of 4 with thionyl chloride and triethylamine afforded the stable cyclic sulfite 5 in 92% yield, which could be even purified by column chromatography. Although nucleophilic displacements are commonly performed on key sulfate intermediates, the activated benzylic position C-1¢ in sulfite 5 is thought to be reactive enough for nucleophilic ring-opening. Treatment of 5 with NaN 3 /DMF at 60°C gave a mixture of azido derivatives 6, 15, 16 epimers at C-1¢, in a ratio R/S = 4, indicating that S N 2 and S N 1-like mechanisms participated in the displacement. In order to avoid epimerization, we decided to use the mixture TMSN 3 /TBAF with increased nucleophilicity and solubility of the azide anion in organic solvents. Thus, the reaction of 5 with TMSN 3 /TBAF in THF at room temperature gave the azido derivative 7 17 as unique compound in 77% yield with the concomitant removal of the silyl protecting group. This fact indicates that the reaction occurred through an S N 2 mechanism allowing the total stereoselective introduction of the azide function. Oxidative cleavage of diol 7 followed by reduction of the aldehyde function with NaBH 4 afforded alcohol 8 in 83% overall yield. In order to confirm that no epimerization at C-1¢ occurred in the reduction, Mosher's ester of compound 8 was prepared.
1 H NMR and 13 C NMR experiments showed that only diastereomer 9 18 was present and no signals for the epimerized derivative could be found. Finally, hydrogenation of 8 using Pd/C (10%) as catalyst afforded the furan amino acid 1 in good yield.
In a similar way, the synthesis of ent-1 was carried out starting from trihydroxypropyl furan 3 (C-1¢, R/S = 19) that was obtained from D-arabinose in 69% yield (Scheme 4). tert-Butyldiphenylsilyl protection followed by sulfite formation afforded 10 (C-1¢, R/S = 23) after purification by column chromatography (Scheme 4). Displacement reaction of 10 using the mixture TMSN 3 /TBAF in THF at room temperature gave the azido derivative 11 (57% after 48 h of reaction). The displacement-deprotection step for compound 10 proved to be slower than for its epimer 5. Besides, partial epimerization was detected (ratio on C-1¢, S/R = 13 = 11/7 measured by 1 H NMR in the crude mixture) which is presumably due to the participation of an S N 1-like mechanism. Attempts to improve the stereoselectivity of the displacement using DMF as solvent or lower temperatures were not successful. Oxidative cleavage of 11 followed by reduction with NaBH 4 afforded alcohol ent-8, that was reduced to give the amino acid derivative ent-1 in good-to-moderate yield (Scheme 4). The enantiomeric purity (92.3%) of ent-8 was determined by formation of the corresponding Mosher's ester. The absolute configuration of C-1¢ in 1 and ent-1 was confirmed in the corresponding precursors 7 and 11 by transformation into their corresponding oxazolidine-2-thione derivatives 13 and 14 (Scheme 5). Appropriate NOEs confirmed the proposed structures. In summary, the synthesis of new chiral furan amino acid analogues of D-and L-serine is described starting from Daldopentoses. In the case of the D-serine analogue 1 the method proved to be very efficient as the final product was obtained enantiomerically pure. For the L-serine analogue ent-1, the method provides the target compound with 92.3% of enantiomeric purity. Compound 1 was easily transformed into the corresponding Fmoc-activated derivative ready to be incorporated into a peptide or peptidomimetic following the Fmoc strategy for solid-phase peptide synthesis. Due to the aromatic character of the furan-3-carboxylic acid, compound 16 is stable which makes it an attractive building block for solid phase peptide synthesis as compared to most OBt esters 21 of Fmocamino acids which are not stable enough and need to be generated in situ. Work is in progress to prepare peptidomimetics with conformational bias by solid phase synthesis using the new scaffold, and to extend this methodology to other constrained hetaryl amino acids. 
